Ovarian Damage During chemotherapy in Autoimmune Diseases: Broad Health Implications beyond Fertility. - Wikidata - awgldk - TriplyDB

Ovarian Damage During chemotherapy in Autoimmune Diseases: Broad Health Implications beyond Fertility.

Ovarian Damage During chemotherapy in Autoimmune Diseases: Broad Health Implications beyond Fertility.

http://www.wikidata.org/entity/Q37105605

about

Rheumatic autoimmune diseases in women and midlife health Hyaluronic acid prevents immunosuppressive drug-induced ovarian damage via up-regulating PGRMC1 expression.Acute immunomodulatory changes during controlled ovarian stimulation: evidence from the first trial investigating the short-term effects of estradiol on biomarkers and B cells involved in autoimmunity.Infertility - Prevention and Management.A grafted ovarian fragment rescues host fertility after chemotherapy.Proceedings from the American College of Rheumatology Reproductive Health Summit: the management of fertility, pregnancy, and lactation in women with autoimmune and systemic inflammatory diseases.Recovery of ovary function impaired by chemotherapy using Chinese herbal medicine in a rat model.Update on fertility preservation from the Barcelona International Society for Fertility Preservation-ESHRE-ASRM 2015 expert meeting: indications, results and future perspectives

P2860

Q33727015-7154B23B-8745-46F3-A991-C9E08AF1A356 Q34830224-5959DA19-0223-4BD6-BCB6-2B631261BC8B Q36378555-1510B85F-55B9-4303-9872-B622A1FF99DC Q39228582-BE1424DE-DCE1-4CAD-B5C7-3672A9CE676B Q39326940-1D54EEA7-B7E4-4276-A46D-BAC4408C89EC Q46166151-AC4582FE-5D69-4D06-908F-21745840DFA3 Q47643562-D2F0A584-943F-4935-963A-B9164E6F9AD8 Q57093082-D8265A01-CC06-4BF0-9930-CFDC55F07C89

P2860

Ovarian Damage During chemotherapy in Autoimmune Diseases: Broad Health Implications beyond Fertility.

http://www.wikidata.org/entity/Q37105605

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on October 2012

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Ovarian Damage During chemothe ...... Implications beyond Fertility.

@en

Ovarian Damage During chemothe ...... Implications beyond Fertility.

@nl

type

label

Ovarian Damage During chemothe ...... Implications beyond Fertility.

@en

Ovarian Damage During chemothe ...... Implications beyond Fertility.

@nl

prefLabel

Ovarian Damage During chemothe ...... Implications beyond Fertility.

@en

Ovarian Damage During chemothe ...... Implications beyond Fertility.

@nl

P1433

Q37105605-179F1B9B-E188-4AC9-8A97-3B8E456F99D6

P1476

Q37105605-E8D6DECF-1B05-4077-A998-E79EA9F8D77F

P2093

Q37105605-211C2301-83BA-4D39-8520-85921C2F3179

Q37105605-679EF1EC-67EB-4771-A097-0214B4ADD396

Q37105605-7E040C28-BB5F-40C5-B80E-69CCC11660D9

Q37105605-8571F2EF-E363-4D07-B92D-8B055A938833

P2860

Q37105605-07A8F8B0-9CEE-447B-A4FA-3D9F8C2182C4

Q37105605-082B8CA9-684F-481F-9560-AC2B60389165

Q37105605-1359B84D-AF6E-428E-B981-B55D5B459E8A

Q37105605-14AD0B01-3208-48A7-B14A-081ADCDC287E

Q37105605-167B13F6-0010-4EDF-83F7-935860466264

Q37105605-248E284B-4DE4-4CA8-AF91-E417A6CDBC57

Q37105605-2D551E45-78DE-4AC8-B9DA-80D72FB121A5

Q37105605-2E50569B-32B5-4C40-9911-1F2A79D77D03

Q37105605-30A15DF4-B901-4784-8758-56937D5646F8

Q37105605-314267CD-269F-4AC2-A036-D28298B1076C

P304

Q37105605-2E81DAA8-261A-49A0-A1CA-F685A88AA503

P31

Q37105605-65A37704-1243-47D3-85BC-A2DE127C19A1

P356

Q37105605-63CAB657-8345-4923-904B-86F214F7873E

P433

Q37105605-9DF5F291-D2A2-4BB3-A830-AE8C1F986422

P478

Q37105605-6A4718F5-0664-426E-BA81-C3ACB0795C97

P577

Q37105605-0B9F862B-183C-44A1-8BF5-BF3794E7F830

P698

Q37105605-E1BAE458-E9FD-43C2-91F9-07614666C6D5

P921

Q37105605-0F162144-ED01-4B73-A4D2-5C7105F3F277

P932

Q37105605-47C8272B-4C87-40A2-8D5C-519A8D1E9466

P356

P1433

Clinical medicine insights. Reproductive health

P1476

Ovarian Damage During chemothe ...... Implications beyond Fertility.

@en

P2093

Emily C Somers

http://www.w3.org/2001/XMLSchema#string

Martha A Ganser

http://www.w3.org/2001/XMLSchema#string

Senait Fisseha

http://www.w3.org/2001/XMLSchema#string

Wendy Marder

http://www.w3.org/2001/XMLSchema#string

P2860

Adjuvant gonadotropin-releasing hormone analogues for the prevention of chemotherapy induced premature ovarian failure in premenopausal women

Women with spontaneous 46,XX primary ovarian insufficiency (hypergonadotropic hypogonadism) have lower perceived social support than control women

Clinical practice. Primary ovarian insufficiency

Increased cardiovascular mortality after early bilateral oophorectomy

Cancer treatment and survivorship statistics, 2012

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

Premature ovarian failure: a systematic review on therapeutic interventions to restore ovarian function and achieve pregnancy

Premature ovarian failure is not premature menopause

Assessing the emotional needs of women with spontaneous premature ovarian failure

Premature menopause or early menopause: long-term health consequences

P304

9-18

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4137/CMRH.S10415

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

2012

http://www.w3.org/2001/XMLSchema#string

P577

2012-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23970822

http://www.w3.org/2001/XMLSchema#string

P921

P932

3747568

http://www.w3.org/2001/XMLSchema#string